Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Fluence PDT with Ranibizumab for AMD
NCT00473642Phase 4Completed
- Sponsor
- Oklahoma State University Center for Health Sciences
- Start
- May 2007
- Primary completion
- May 2009
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of verteporfin in exudative age-related macular degeneration, sponsored by Oklahoma State University Center for Health Sciences. Started May 2007; status: completed.
02
Drugs
verteporfin
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00473642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473642.